Health Technology Assessment
Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours: systematic review and economic evaluation
-
Type:Extended Research Article Our publication formats
-
Journal:
-
Issue:Volume: 9, Issue: 25
-
Published:
-
Citation:Wilson J, Connock M, Song F, Yao G, Fry-Smith A, et al. Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours: systematic review and economic evaluation. Health Technol Assess 2005;9(25). https://doi.org/10.3310/hta9250
-
DOI: